Alzheimer's Fast Track 2024

More than 60 scientists from all career stages gathered to discuss critical topics in the field of Alzheimer’s disease research at BrightFocus Foundation’s 16th annual Alzheimer’s Fast Track, held Oct. 2-4 in Chicago, IL.

Speakers at Alzheimer's Fast Track 2024

About Alzheimer’s Fast Track

Learn from experts in the field of Alzheimer’s disease and related dementias at the Alzheimer’s Fast Track workshop. Designed for graduate students, postdoctoral fellows, and other early-career scientists focused on Alzheimer’s disease research, this immersive learning experience will accelerate your knowledge, expertise, and visibility in this exciting field.

Alzheimer's Fast Track logo

2024 Event Details

October 2-4, 2024
Chicago, Illinois
Official pre-meeting to Society for Neuroscience

 

Contact researchgrants@brightfocus.org with questions.

What Attendees Are Saying

I cannot believe how much this BrightFocus Fast Track has shaped my knowledge, my career and me personally. I also made friends forever. Not only I am so much more prepared and more confident to write grants but also I gained skills to communicate and to share my science. This workshop is the greatest idea to help students build their careers more successfully. Every scientist should go through a workshop like this one. Thank you for the opportunity!

Amira Latif-Hernandez, PhD, Alzheimer’s Disease Research Grant Recipient and Fast Track Attendee

a headshot of Dr. Latif-Hernandez
The BrightFocus team shows genuine care for their fellows and their individual career paths, which was evident during the Fast Track event. The opportunity to easily connect with mentors and receive personalized advice truly stood out.

Julie Ottoy, PhD, Alzheimer’s Disease Research Grant Recipient and Fast Track Attendee

a headshot of Dr. Ottoy

Co-Chairs

Frank LaFerla, PhD headshot

Frank LaFerla, PhD

University of California, Irvine

Cynthia Lemere headshot

Cynthia Lemere, PhD

Brigham and Women’s Hospital, Harvard Medical School

Sharyn Rossi, PhD

Sharyn Rossi, PhD

BrightFocus Foundation

Harry Steinbusch headshot

Harry Steinbusch, PhD

Maastricht University,
The Netherlands

Related News & Research Breakthroughs

Browse related news and research breakthroughs.
Laboratory assistant draws blood from a patient's vein with a disposable syringe.

Article

Breaking News Dispatch: New Findings on GLP-1 Drugs and Alzheimer’s, Novel Treatments in Development, and More

Get the latest news from the 2025 Clinical Trials on Alzheimer’s Disease (CTAD) conference.

Stacey Sukoff Rizzo, PhD, far left, shares feedback with students.

Article

4 Takeaways from Alzheimer’s Fast Track 2025

This innovative meeting hosted by BrightFocus Foundation bridges cutting-edge science, mentorship, and community building for early-career researchers.

Understanding Alzheimer's and Exploring New Frontiers in Treatment thumbnail.

Article

Understanding Alzheimer’s & Exploring New Frontiers in Treatment

Watch a conversation inspired by the documentary film Taking Care and the latest research in Alzheimer’s therapies.

Article

Shaping the Future of National Alzheimer’s Research Priorities

BrightFocus Foundation’s VP of Scientific Affairs helped set national research priorities at the federal Alzheimer’s Disease-Related Dementias Summit, influencing how billions in NIH funding will advance dementia research and care.

Dr. Sharyn Rossi and Dr. Keith Hengen.

Article

New Clues in the Fight Against Alzheimer’s: Q&A with Dr. Keith Hengen

During World Alzheimer’s Month, Alzheimer’s Disease Research grantee Dr. Keith Hengen joined BrightFocus’ Dr. Sharyn Rossi on Instagram Live to talk brain health—how the brain functions, why quality sleep matters, and tips to keep your brain healthy.

Diagonal model of abstract DNA double helix, luminous in virtual space. Vector illustration.

Article

Targeting Genetic Triggers of Inflammation in Alzheimer’s Disease

A BrightFocus Alzheimer’s Disease Research-funded scientist is investigating how “jumping genes” may fuel brain inflammation in Alzheimer’s—and whether blocking them could prevent or slow dementia.